AMTB, a TRPM8 antagonist, suppresses growth and metastasis of osteosarcoma through repressing the TGFβ signaling pathway

Since its first identification in prostate cancers and prostate tissues, transient receptor potential melastatin-subfamily member 8 (TRPM8) is subsequently found to be overexpressed in a wide range of cancers and is shown to be implicated in tumorigenesis and tumor progression. Here, we used N-(3-am...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yujie, Leng, Ao, Li, Lin, Yang, Bo, Shen, Shihui, Chen, Hui, Zhu, Enhao, Xu, Qiyue, Ma, Xiaoyu, Shi, Peilin, Liu, Yun, Liu, Tielong, Li, Lei, Li, Kun, Zhang, Dan, Xiao, Jianru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971393/
https://www.ncbi.nlm.nih.gov/pubmed/35361751
http://dx.doi.org/10.1038/s41419-022-04744-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971393/
https://www.ncbi.nlm.nih.gov/pubmed/35361751
http://dx.doi.org/10.1038/s41419-022-04744-6

Ejemplares similares